Anti-Tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer

NCT02343835 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fuda Cancer Hospital, Guangzhou